These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
576 related items for PubMed ID: 20593050
1. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, Agcheli K. J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050 [Abstract] [Full Text] [Related]
2. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels. Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D. Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814 [Abstract] [Full Text] [Related]
3. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z. Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611 [Abstract] [Full Text] [Related]
4. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases]. Ding XJ, Li SB, Li SZ, Liu HS, Liu B, Xu FM, Gu RW. Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637 [Abstract] [Full Text] [Related]
5. [Diagnostic value of five serum markers for liver fibrosis]. Luo R, Yang S, Xie J, Zhao Z, He Y, Yao J. Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388 [Abstract] [Full Text] [Related]
6. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B]. Chen YP, Feng XR, Dai L, Ding HB, Zhang L. Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522 [Abstract] [Full Text] [Related]
7. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients]. Park JH, Park CK, Kim ES, Park SY, Jo CM, Tak WY, Kweon YO, Kim SK, Choi YW. Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747 [Abstract] [Full Text] [Related]
8. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M. Acta Biochim Pol; 2011 Jun; 58(4):563-6. PubMed ID: 22140659 [Abstract] [Full Text] [Related]
9. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. Hartley JL, Brown RM, Tybulewicz A, Hayes P, Wilson DC, Gillett P, McKiernan P. J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988 [Abstract] [Full Text] [Related]
10. [Serum fibrosis markers in diagnosing liver fibrosis]. Liu J, Wang JY, Lu Y. Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325 [Abstract] [Full Text] [Related]
11. Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B. Li F, Zhu CL, Zhang H, Huang H, Wei Q, Zhu X, Cheng XY. Braz J Infect Dis; 2012 Jun; 16(1):9-14. PubMed ID: 22358349 [Abstract] [Full Text] [Related]
12. Serum hyaluronic acid as a marker of hepatic fibrosis. Khan JA, Khan FA, Dilawar M, Ijaz A, Khan NA, Mehmood T. J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578 [Abstract] [Full Text] [Related]
13. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, de Knegt RJ, van Vuuren AJ. Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677 [Abstract] [Full Text] [Related]
14. [Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis]. Liang XH, Zheng H. Hunan Yi Ke Da Xue Xue Bao; 2002 Feb 28; 27(1):67-8. PubMed ID: 12575242 [Abstract] [Full Text] [Related]
15. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection. Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R. J Viral Hepat; 2009 Jul 28; 16(7):513-8. PubMed ID: 19200132 [Abstract] [Full Text] [Related]
16. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases. Tamano M, Kojima K, Akima T, Murohisa T, Hashimoto T, Uetake C, Sugaya T, Nakano M, Hiraishi H, Yoneda M. Hepatogastroenterology; 2012 May 28; 59(115):826-30. PubMed ID: 22469726 [Abstract] [Full Text] [Related]
17. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease]. Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH. Korean J Hepatol; 2009 Dec 28; 15(4):454-63. PubMed ID: 20037264 [Abstract] [Full Text] [Related]
18. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS, Wang BE, Wang TL, Jia JD, Qian LX. Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 28; 12(8):467-70. PubMed ID: 15329205 [Abstract] [Full Text] [Related]
19. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin. Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP. J Viral Hepat; 2006 Oct 28; 13(10):643-51. PubMed ID: 16970595 [Abstract] [Full Text] [Related]
20. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B. Zhu CL, Li WT, Li Y, Gao RT. J Dig Dis; 2012 Nov 28; 13(11):558-63. PubMed ID: 23107442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]